Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
1.
Mil Med ; 183(7-8): e332-e333, 2018 07 01.
Article in English | MEDLINE | ID: mdl-29547956

ABSTRACT

Introduction: Blastomyces dermatitidis is a dimorphic fungus endemic to the Mississippi River valley. We describe a rare case of chronic pulmonary blastomycosis complicated by large pulmonary cavitation in a young service member who was misdiagnosed with active pulmonary tuberculosis. Case Presentation: A 25-year-old active duty male presented to his primary care provider with complaints of hemoptysis, fatigue, weight loss, and fever. Computed tomography chest with contrast identified a large cavitary lesion in the right upper lobe (RUL). The patient was admitted to an outside hospital and he underwent bronchoscopy with transbronchial biopsies and bronchoalveolar lavage of the RUL. Histology and cultures were unremarkable however; Histoplasma serum antigen was positive. The patient was empirically treated for active pulmonary tuberculosis and soon discharged. He returned for medical evaluation 3 mo later with continued hemoptysis. Repeat bronchoscopy with transbronchial biopsies of the RUL cavity grew Blastomyces dermatitidis. The patient's symptoms resolved and chest imaging significantly improved with initiation of itraconazole. Discussion: Chronic pulmonary blastomycosis can present with a constellation of symptoms that may be indistinguishable from chronic pulmonary histoplasmosis, pulmonary tuberculosis, or lung cancer. Knowledge of endemic diseases and a thorough travel history should be an integral part of a military physician's infectious disease evaluation.


Subject(s)
Blastomycosis/diagnosis , Tuberculosis, Pulmonary/physiopathology , Adult , Blastomyces/pathogenicity , Blastomycosis/physiopathology , Diagnosis, Differential , Fatigue/etiology , Fever/etiology , Hemoptysis/etiology , Humans , Male , Military Personnel , Tuberculosis, Pulmonary/diagnosis , Weight Loss
3.
PLoS Pathog ; 13(5): e1006356, 2017 May.
Article in English | MEDLINE | ID: mdl-28542595

ABSTRACT

Our understanding of persistence and plasticity of IL-17A+ memory T cells is clouded by conflicting results in models analyzing T helper 17 cells. We studied memory IL-17A+ CD8+ T-cell (Tc17) homeostasis, persistence and plasticity during fungal vaccine immunity. We report that vaccine-induced memory Tc17 cells persist with high fidelity to the type 17 phenotype. Tc17 cells persisted durably for a year as functional IL-17A+ memory cells without converting to IFNγ+ (Tc1) cells, although they produced multiple type I cytokines in the absence of residual vaccine antigen. Memory Tc17 cells were canonical CD8+ T cells with phenotypic features distinct from Tc1 cells, and were Ror(γ)thi, TCF-1hi, T-betlo and EOMESlo. In investigating the bases of Tc17 persistence, we observed that memory Tc17 cells had much higher levels of basal homeostatic proliferation than did Tc1 cells. Conversely, memory Tc17 cells displayed lower levels of anti-apoptotic molecules Bcl-2 and Bcl-xL than Tc1 cells, yet were resistant to apoptosis. Tc1 cells required Bcl-2 for their survival, but Bcl-2 was dispensable for the maintenance of Tc17 cells. Tc17 and Tc1 cells displayed different requirements for HIF-1α during effector differentiation and sustenance and memory persistence. Thus, antifungal vaccination induces durable and stable memory Tc17 cells with distinct requirements for long-term persistence that distinguish them from memory Tc1 cells.


Subject(s)
Blastomyces/immunology , Blastomycosis/immunology , Fungal Vaccines/immunology , Immunologic Memory , Interferon-gamma/immunology , Th17 Cells/immunology , Animals , Blastomycosis/microbiology , Blastomycosis/physiopathology , Blastomycosis/prevention & control , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/immunology , Cell Differentiation , Humans , Interleukin-17/immunology , Mice , Mice, Inbred C57BL , Th17 Cells/cytology
4.
Emerg Infect Dis ; 22(2): 306-8, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26812599

ABSTRACT

Since the 2013 description of Blastomyces gilchristii, research describing the virulence or clinical outcome of B. gilchristii infection has been lacking. We report molecular evidence of B. gilchristii as an etiologic agent of fatal acute respiratory distress syndrome. B. gilchristii infection was confirmed by PCR and sequence analysis.


Subject(s)
Blastomyces/genetics , Blastomycosis/microbiology , Respiratory Distress Syndrome/microbiology , Adult , Antifungal Agents/therapeutic use , Blastomyces/classification , Blastomycosis/diagnosis , Blastomycosis/drug therapy , Blastomycosis/physiopathology , DNA, Intergenic , Fatal Outcome , Female , Humans , Radiography, Thoracic , Respiratory Distress Syndrome/diagnosis , Respiratory Distress Syndrome/drug therapy , Respiratory Distress Syndrome/physiopathology
5.
Lab Med ; 45(3): e123-7, 2014.
Article in English | MEDLINE | ID: mdl-25217516

ABSTRACT

PATIENT: A 49-year-old white man. CHIEF COMPLAINT: Shortness of breath, fever, and ongoing unintended weight loss. HISTORY OF PRESENT ILLNESS: The patient had arrived at the emergency department of a hospital in St. Augustine, Florida with coughing and progressive shortness of breath. He reported that he had been experiencing these symptoms for the past 6 weeks. He was examined by his primary physician, who had prescribed him a course of antibiotics and treated him on an outpatient basis. The patient reported no improvement in his symptoms at present, despite the antibiotics. He mentioned that he had traveled to St. Augustine, Florida approximately 10 days previously. Medical personnel in the emergency department subsequently performed a chest x-ray on the patient, as well as computed tomography (CT) scanning of his lymphadenopathy. MEDICAL AND FAMILY HISTORY: Positive for hypertension, diabetes mellitus, and osteoporosis. He reported that he has chewed 2 packs of chewing tobacco per day for the past 30 years, occasionally drinks alcohol, and is a nonsmoker with no known allergies. FAMILY HISTORY: Noncontributory. SOCIAL HISTORY: Noncontributory. PHYSICAL EXAMINATION RESULTS: The patient exhibited mild respiratory distress; however, he was awake, alert, and oriented, with a temperature of 37.3°C. He also exhibited poor respiratory effort with diffuse expiratory rhonchi. His heart rate and heart rhythm were regular, with no murmurs, gallops, or rubs. His bowel sounds were positive; he exhibited no organomegaly and no cyanosis, clubbing, or edema of his extremities.


Subject(s)
Blastomycosis/physiopathology , Pneumonia/physiopathology , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Blastomyces/pathogenicity , Blastomycosis/drug therapy , Blastomycosis/microbiology , Humans , Itraconazole/therapeutic use , Male , Middle Aged , Pneumonia/drug therapy , Pneumonia/microbiology , Virulence
7.
Transpl Infect Dis ; 14(1): 17-23, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21749587

ABSTRACT

AIM: A review of the clinical presentation, diagnosis, treatment and outcomes of 30 solid organ transplant recipients (SOTRs) with histoplasmosis or blastomycosis from 3 Midwestern academic medical centers. BACKGROUND: The endemic fungal pathogens, Histoplasma capsulatum and Blastomyces dermatitidis, may cause severe infection in SOTRs. In this report, we describe the clinical presentation, diagnosis, treatment, and outcomes of these endemic fungal infections (EFIs) among SOTRs at 3 academic transplant centers. METHODS: A retrospective review was conducted of SOTRs with histoplasmosis or blastomycosis from 3 Midwestern medical centers in the United States. Data collected included demographics, immunosuppression, clinical presentation, method of diagnosis, antifungal treatment, response to therapy, and patient and graft survival. RESULTS: Between 1996 and 2008, 30 transplant recipients with histoplasmosis or blastomycosis were identified, giving a cumulative incidence of infection of 0.50% (30/5989); 73% of the study patients were renal transplant recipients, and the median time to disease onset after transplantation was 10.5 months. The lungs were the most common site of infection (83%), and 60% had disseminated disease. Urine antigen testing was positive in all patients in whom it was performed (23/23). Initial antifungal therapy consisted of amphotericin B in 70%, and 87% received azoles, typically itraconazole (83%). Two patients developed relapsed infection and 7 patients had graft failure after EFI. Overall mortality was 30%, with an attributable mortality of 13%. CONCLUSIONS: As in several previous single-center studies, the incidence of post-transplant histoplasmosis and blastomycosis was <1%, but often resulted in disseminated infection. In this cohort, EFI was associated with a high rate of allograft loss and overall mortality.


Subject(s)
Blastomyces/isolation & purification , Blastomycosis , Histoplasma/isolation & purification , Histoplasmosis , Organ Transplantation/adverse effects , Academic Medical Centers , Adult , Aged , Antifungal Agents/therapeutic use , Blastomycosis/epidemiology , Blastomycosis/microbiology , Blastomycosis/mortality , Blastomycosis/physiopathology , Female , Histoplasmosis/epidemiology , Histoplasmosis/microbiology , Histoplasmosis/mortality , Histoplasmosis/physiopathology , Humans , Incidence , Male , Middle Aged , Midwestern United States/epidemiology , Young Adult
8.
Semin Respir Crit Care Med ; 32(6): 745-53, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22167402

ABSTRACT

Blastomyces dermatitidis is acquired in almost all cases via inhalation, and pulmonary disease is the most frequent clinical manifestation of blastomycosis. Pulmonary disease can range from asymptomatic infection to rapidly severe and fatal disease. Most cases will present as pneumonia, either acute or chronic, or as a lung mass. In rare cases pulmonary blastomycosis is associated with the acute respiratory distress syndrome. Blastomycosis can present as isolated pulmonary disease or along with coexisting extrapulmonary disease that usually will involve the skin, bony structures, genitourinary tract, or central nervous system. Diagnosis is largely based on isolation of the organism via culture or visualization of the organism in clinical specimens. Detection of urinary Blastomyces antigen is a recent addition to diagnostic options. Itraconazole is the drug of choice for most forms of the disease; amphotericin B is reserved for the more severe forms. Newer azoles such as voriconazole and posaconazole have a limited role in the treatment of pulmonary blastomycosis.


Subject(s)
Blastomyces/pathogenicity , Blastomycosis , Lung Diseases, Fungal , Antifungal Agents/therapeutic use , Blastomyces/immunology , Blastomycosis/diagnosis , Blastomycosis/drug therapy , Blastomycosis/epidemiology , Blastomycosis/physiopathology , Blastomycosis/prevention & control , Humans , Lung Diseases, Fungal/diagnosis , Lung Diseases, Fungal/drug therapy , Lung Diseases, Fungal/epidemiology , Lung Diseases, Fungal/physiopathology , Lung Diseases, Fungal/prevention & control , North America/epidemiology
9.
Rev. iberoam. micol ; 27(4): 210-212, oct.-dic. 2010. ilus
Article in Spanish | IBECS | ID: ibc-82967

ABSTRACT

Antecedentes. La blastomicosis es una enfermedad infecciosa granulomatosa, causada por el hongo dimorfo Blastomyces dermatitidis. Predomina en Estados Unidos de América, y en México solo se han reportado 2 casos sistémicos importados. La forma primaria cutánea es la presentación clínica menos frecuente de la enfermedad y ocurre después de la inoculación del hongo por traumatismo. Objetivos. Se presenta el caso de un hombre de 54 años de edad, originario de Guadalajara, México, y residente en Chicago, Estados Unidos. Presentaba en la región frontal y surco nasogeniano derecho 2 nódulos verrugosos de 8mm de diámetro de 4 semanas de evolución. Métodos. Se realizó un estudio histopatológico (tinciones de hematoxilina-eosina, Gomori-Grocott y ácido peryódico de Schiff), además, estudio micológico (directo con KOH y cultivos en agar Sabouraud y micobiótico). Además, se realizaron otros estudios que descartaron afección sistémica. Resultados. La biopsia mostró una dermis con infiltrado inflamatorio compuesto por linfocitos, neutrófilos, histiocitos y células gigantes multinucleadas, y escasas levaduras monogemantes con base ancha y rodeadas por un halo. Al examen directo con KOH, se observaron levaduras monogemantes de 8 a 10mm de diámetro de B. dermatitidis. En el cultivo a 35°C creció una colonia blanca, plegada que, con el tiempo, se tornó amarillenta y cerebriforme. Resultados. Se indicó tratamiento con itraconazol a dosis de 200mg/d durante 2 meses con curación clínica y micológica. Conclusiones. El caso presentado podría ser el primero importado en México donde la blastomicosis se presenta solo con lesiones cutáneas y sin compromiso sistémico(AU)


Background. Blastomycosis is a granulomatous infectious disease. It is caused by the dimorphus fungus Blastomyces dermatitidis. It predominates in the United States of America, but in Mexico two systemic imported cases have been reported. Cutaneous primary blastomycosis is a rare clinical presentation, which occurs after traumatic inoculation of the fungus. Objectives. We present a case of a 54 year old male, born in Guadalajara, Mexico, and living in Chicago, USA, who had two verrucous nodules (8mm in diameter) on the forehead and right nasogenian fold, of 4 weeks progression. Methods. We made a histopathological study (hematoxylin and eosin, Gomori Groccot and periodic acid-Schiff stains) and mycology studies (direct microscopic examination, Sabouraud and mycobiotic agar cultures). Multiple studies were made with no evidence of systemic spread. Results. Biopsy showed a dermal inflammatory infiltrate made up of lymphocytes, neutrophils, histiocytes and multinucleated giant cells. A few large, haloed, broad-based budding yeasts were also observed. Direct examination with KOH revealed broad-based budding yeasts, 10ìm in diameter. Culture at 35°C yielded a white, pleated colony, which changed into a yellowish cerebriform. Multiple studies were made with no evidence of systemic spread. Results. Itraconazole 200mg qd PO was given over a 2 month period, with a complete clinical and mycological response. Conclusions. This is the first imported case in Mexico of blastomycosis with cutaneous lesions without systemic involvement(AU)


Subject(s)
Humans , Male , Middle Aged , Blastomycosis/diagnosis , Blastomycosis/therapy , Blastomyces/isolation & purification , Blastomyces/pathogenicity , Biopsy , Itraconazole/therapeutic use , Microscopy , Mycology/methods , Blastomycosis/microbiology , Blastomycosis/physiopathology , Radiography, Thoracic
10.
Am J Med Sci ; 337(4): 293-4, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19402207

ABSTRACT

Muscle involvement is an extremely rare manifestation of blastomycosis. We, therefore, report a case of a large gluteal muscle abscess caused by Blastomyces dermatitidis in a young, immunocompetent male. In addition, we review the literature to further characterize the syndrome of skeletal muscle blastomycosis.


Subject(s)
Abscess/etiology , Abscess/microbiology , Blastomyces/pathogenicity , Blastomycosis/complications , Muscle, Skeletal , Abscess/pathology , Antifungal Agents/therapeutic use , Blastomycosis/drug therapy , Blastomycosis/physiopathology , Humans , Male , Muscle, Skeletal/microbiology , Muscle, Skeletal/pathology , Young Adult
11.
Chest ; 133(6): 1478-1480, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18574291

ABSTRACT

ARDS secondary to blastomycosis is associated with a high mortality rate despite appropriate antifungal therapy. Corticosteroids are of proven benefit in the treatment of severe Pneumocystis jiroveci pneumonia and are recommended for the treatment of severe pulmonary infections with Histoplasma capsulatum. However, their role in the treatment of severe pulmonary infections with Blastomyces dermatitidis has not been established. We report the cases of two previously healthy men who presented with severe ARDS secondary to blastomycosis. Refractory hypoxemia developed in both patients despite adequate antifungal coverage with amphotericin B. Dramatic improvement was seen in each patient after initiation of corticosteroids in addition to amphotericin B. Both patients survived and did well on follow-up. We suggest that treatment with corticosteroids may be of benefit in patients with blastomycosis-induced ARDS. This may be due to a decrease in the severity of the inflammatory response.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Blastomycosis/complications , Blastomycosis/drug therapy , Respiratory Distress Syndrome/etiology , Adult , Antifungal Agents/therapeutic use , Blastomycosis/physiopathology , Humans , Male , Positive-Pressure Respiration , Respiratory Distress Syndrome/therapy
12.
Transpl Infect Dis ; 9(4): 310-7, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17428278

ABSTRACT

BACKGROUND: Blastomyces dermatitidis, the etiologic agent of blastomycosis, causes severe disease and substantial mortality in those immunocompromised by acquired immunodeficiency syndrome or malignancy. In solid organ transplant recipients, the epidemiology, clinical features, and outcomes have not been fully described. METHODS: We conducted a retrospective case-series at the University of Wisconsin Hospital and Clinics. Case patients were solid organ transplant recipients with blastomycosis. RESULTS: From 1986 to 2004, we identified 11 cases of post-transplant blastomycosis with 64% occurring between 2000 and 2004. Onset of infection occurred a median of 26 months post transplantation with near equal distribution before and after the first year of transplantation. Rejection did not precede any case of post-transplant blastomycosis. Opportunistic co-infections were common, occurring in 36% of patients. Pneumonia was the most common clinical presentation and was frequently complicated by acute respiratory distress syndrome (ARDS). Extrapulmonary disease predominantly involved the skin and spared the central nervous system. The overall mortality rate was 36%; however, this increased to 67% in those with ARDS. None of the surviving patients relapsed or received routine secondary antifungal prophylaxis. CONCLUSION: Blastomycosis is an uncommon infection following solid organ transplantation that is frequently complicated by ARDS, dissemination, and opportunistic co-infection. After cure, post-transplant blastomycosis may not require lifelong antifungal suppression.


Subject(s)
Blastomycosis/epidemiology , Organ Transplantation/adverse effects , Adult , Aged , Blastomyces/isolation & purification , Blastomycosis/microbiology , Blastomycosis/mortality , Blastomycosis/physiopathology , Female , Hospitals, University , Humans , Male , Middle Aged , Pneumonia/complications , Pneumonia/microbiology , Respiratory Distress Syndrome/etiology , Wisconsin
13.
Emerg Infect Dis ; 12(8): 1242-4, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16965704

ABSTRACT

We investigated a cluster of blastomycosis in 8 humans and 4 dogs in a rural North Carolina community. Delayed diagnosis, difficulty isolating Blastomyces dermatitidis in nature, and lack of a sensitive and specific test to assess exposure make outbreaks of this disease difficult to study.


Subject(s)
Blastomyces/isolation & purification , Blastomycosis/epidemiology , Disease Outbreaks , Dog Diseases/epidemiology , Lung Diseases, Fungal/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Blastomycosis/microbiology , Blastomycosis/physiopathology , Dog Diseases/microbiology , Dogs , Female , Humans , Lung Diseases, Fungal/microbiology , Lung Diseases, Fungal/physiopathology , Male , Middle Aged , North Carolina/epidemiology , Rural Population
14.
J Miss State Med Assoc ; 46(7): 198-201, 2005 Jul.
Article in English | MEDLINE | ID: mdl-16118997

ABSTRACT

56 year-old male presented to the University of Mississippi Medical Center emergency department (ED) with complaints of progressive shortness of breath, productive cough, fever, and malaise. His past medical history was significant for hypertension as well as a 60 pack-year history of smoking. Upon arrival to the ED he had a temperature of 103.6 degrees F, blood pressure of 80/40 mm Hg, a pulse of 110 beats per minute, respirations of 28 per minute, and an oxygen saturation of 50% on room air. He appeared to be in significant respiratory distress. Lung examination revealed diffuse bilateral rhonchi and wheezes in all lung fields. He was emergently intubated. Chest radiograph demonstrated a miliary pattern scattered throughout all lung fields in addition to parenchymal opacities. A complete blood count revealed a white blood cell count of 33,500 10(3)/microL, hematocrit of 37%, and platelets of 906,000 10(3)/uL. Blood urea nitrogen and creatinine were 27 mg/dL and 1.0 mg/dL, respectively. Initial ABG on 100% oxygen showed pH 7.15, pCO2 82 mm Hg, and pO2 62 mm Hg. Troponin I was negative. An electrocardiogram demonstrated sinus tachycardia. Blood and urine cultures were obtained.


Subject(s)
Antifungal Agents/therapeutic use , Blastomycosis/diagnosis , Pneumonia/diagnosis , Blastomycosis/drug therapy , Blastomycosis/physiopathology , Diagnosis, Differential , Disease Progression , Dyspnea/diagnosis , Endemic Diseases , Fatal Outcome , Humans , Inhalation Exposure/adverse effects , Male , Middle Aged , Pneumonia/microbiology
15.
Clin Infect Dis ; 34(10): 1310-6, 2002 May 15.
Article in English | MEDLINE | ID: mdl-11981725

ABSTRACT

Blastomyces dermatitidis is a dimorphic fungus endemic to Canada and the United States. Few reports regarding blastomycosis in Canada have been published. We retrospectively reviewed the medical charts of 143 patients with confirmed cases of blastomycosis diagnosed in hospitals in Manitoba, Canada, from 1988 through 1999. The annual incidence rate of blastomycosis in Manitoba was 0.62 cases per 100,000 population, compared with 7.11 cases per 100,000 population in the Kenora, Ontario district. The average age of patients was 38.0 years, and males accounted for 65.0% of cases. An increased incidence of blastomycosis was observed in the Aboriginal subpopulation. Organ systems involved were as follows: respiratory system (93.0% of cases), skin (21.0%), bone (13.3%), genitourinary tract (1.4%), and the central nervous system (1.4%); 6.3% of patients died, and death was associated with a short clinical course. This study provides a summary of the current status of blastomycosis in this area of endemicity in Canada.


Subject(s)
Blastomycosis/epidemiology , Cross Infection/epidemiology , Adolescent , Adult , Aged , Blastomycosis/ethnology , Blastomycosis/mortality , Blastomycosis/physiopathology , Child , Child, Preschool , Cross Infection/ethnology , Cross Infection/mortality , Cross Infection/physiopathology , Female , Humans , Infant , Infant, Newborn , Male , Manitoba/epidemiology , Middle Aged , Retrospective Studies
16.
Clin Pediatr (Phila) ; 39(1): 27-31, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10660815

ABSTRACT

In order to determine the pulmonary outcome following blastomycosis during childhood, we compiled a case series of hospitalized patients from a retrospective review with later recall for pulmonary function testing, coupled with prospective measurements of pulmonary function in three patients, at a tertiary care children's hospital. A convenience sample of five of 17 patients hospitalized with pulmonary blastomycosis, whose mean age at the time of diagnosis was 10.6 +/- 5.5 years, was recalled at a mean of 4.5 +/- 3.5 years after diagnosis. Three patients more recently hospitalized underwent serial pulmonary function testing (PFT) prospectively from as soon after the acute infection as their condition permitted. All but two patients had normal PFT when last seen. The two patients with persistent pulmonary sequelae were among those followed up prospectively and had more severe clinical and radiographic pictures at the outset. Pulmonary function in children who suffered from pulmonary blastomycosis is normal in most patients at follow-up years later. Severe radiographic disease and slow recovery over months portend long-term sequelae.


Subject(s)
Blastomyces/isolation & purification , Blastomycosis/physiopathology , Lung Diseases, Fungal/physiopathology , Lung/physiopathology , Adolescent , Adult , Blastomycosis/microbiology , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Lung Diseases, Fungal/microbiology , Male , Recovery of Function , Respiratory Function Tests , Retrospective Studies , Treatment Outcome
18.
Am J Phys Anthropol ; 106(1): 47-60, 1998 May.
Article in English | MEDLINE | ID: mdl-9590524

ABSTRACT

The present study addresses the specificity of lytic osseous impact for distinguishing among metastatic cancer, tuberculosis, and fungal disease. Osseous impact is used in this manuscript as a convention to describe the macroscopic appearance of defleshed bones affected by the disease. Osseous changes in the skeleton of a 47-year-old black male, diagnosed in life as having blastomycosis, were characterized and compared to lytic lesions observed in ten individuals with tuberculosis and six with metastatic cancer in the Terry and Hamman-Todd Collections. Apparent distinguishing characteristics are identified. Eroded areas, present as fronts of resorption or the result of space-occupying masses in blastomycosis, with protruding, short, blunt, 1 x 2 mm spicules of new bone, are surrounded by periosteal reaction. These differed from smooth zones of resorption and coalesced lesions, with a smoothed marginal zone and space-occupied appearance--bone-displacing mass--in tuberculosis and lytic (nonpermeative) lesions of metastatic cancer. Displacing is a convention (an artificial term) denoting bone resorption and reformation at the outer edge of the tumor mass, giving the impression that the surrounding bone had expanded beyond its original margins. Irregular trabeculae are occasionally preserved in the margins, but remodeling in the form of blunting of those trabeculae is not observed macroscopically in either tuberculosis or metastatic cancer. Two apparently specific lesion types are noted in blastomycosis. Periosteal reaction surrounding fronts of resorption appears specific, at least for nonarticular osseous lytic lesions, among the three entities studied. Remodeling of isolated internal trabeculae in the space-occupying mass lesions of blastomycosis also appears unique among the three disorders studied. Comparison with coccidioidomycosis suggests that extrapolation of blastomycosis findings to other fungal diseases is feasible; description of additional clinically diagnosed cases is awaited.


Subject(s)
Blastomycosis/physiopathology , Bone and Bones/pathology , Anthropology, Physical/methods , Blastomycosis/diagnosis , Diagnosis, Differential , Fossils , Humans , Male , Middle Aged , Neoplasm Metastasis/pathology , Tuberculosis/pathology
19.
Acta AWHO ; 17(1): 6-10, jan.-mar. 1998.
Article in Portuguese | LILACS | ID: lil-209669
SELECTION OF CITATIONS
SEARCH DETAIL
...